Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
about
The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseasesAcquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.Clinical application of 5alpha-reductase inhibitors.Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.Prostatic stem cells.5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.Estrogen and androgen signaling in the pathogenesis of BPH.Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function.Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status.Importance of the intracrine metabolism of adrenal androgens in androgen-dependent prostate cancer.Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer.Comparative study of glycoconjugates of the rat prostatic lobes by lectin histochemistry.Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors.
P2860
Q21285041-81359E22-AAD1-4472-9C48-150F0B58F514Q24815477-43DD4C6A-C244-4C48-ADAF-D1EFD23C5E83Q33623428-5CBD515A-3A91-42AF-97B5-C1B11467D5AFQ33943526-6CF26A12-AE76-4CAB-8F7A-960E3A8C01DDQ34313221-8EB366C0-C150-4C1A-8C71-44ECD5E6B011Q34736918-72E0D3F4-18F2-418F-96EB-7234491E8366Q34887797-CEE7830F-9120-4627-98A0-A2533BA89C1AQ37828063-38BB6A4E-EA14-4D2E-8D79-EFBAF60CA32DQ38239520-20DCD918-BC8D-4BB1-8A4E-3ACF3731458EQ38296539-E99A52C1-278D-48BD-9A75-A99B192CF9F3Q40154021-78D2952C-B4BF-4FD2-9F87-4DB17E7BFAE2Q42451991-AA65281D-31C9-41A1-B683-ABDAC3F6125FQ42467745-8116EA58-A0EF-4072-832D-6ED030DAA787Q42936023-C79200AC-CD75-4B06-88FB-BB7805BDBB6BQ44785091-69D721B3-3D30-4515-9617-7886A2658BFB
P2860
Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Differential expression of 5 a ...... tate and prostatic carcinomas.
@ast
Differential expression of 5 a ...... tate and prostatic carcinomas.
@en
Differential expression of 5 a ...... tate and prostatic carcinomas.
@nl
type
label
Differential expression of 5 a ...... tate and prostatic carcinomas.
@ast
Differential expression of 5 a ...... tate and prostatic carcinomas.
@en
Differential expression of 5 a ...... tate and prostatic carcinomas.
@nl
prefLabel
Differential expression of 5 a ...... tate and prostatic carcinomas.
@ast
Differential expression of 5 a ...... tate and prostatic carcinomas.
@en
Differential expression of 5 a ...... tate and prostatic carcinomas.
@nl
P2093
P2860
P1433
P1476
Differential expression of 5 a ...... tate and prostatic carcinomas.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E
P577
1996-10-01T00:00:00Z